AC
LUNG icon

Almitas Capital’s Pulmonx LUNG Stock Holding History

Almitas Capital’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
+1,064,202
New +$1.47M 0.33% 50

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Almitas Capital's LUNG Position: Q2 2026 in Review

Almitas Capital opened a new position in Pulmonx (LUNG) in Q2 2026: 1,064,202 shares worth $1.38M. The stake represents 0.33% of the portfolio and ranks #50 among its holdings.

108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Almitas Capital held 1,064,202 shares of Pulmonx worth $1.38M as of Q2 2026.
  • Pulmonx was a new Almitas Capital position in Q2 2026.
  • Pulmonx made up 0.33% of Almitas Capital's portfolio in Q2 2026, its #50 holding.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Almitas Capital's 13F filing for Q2 2026, filed 17 Aug 2026.